Response to the Coronavirus public health emergency
General Secretary Dave Penman outlines the FDA’s response to the Coronavirus public health emergency and the steps we are taking to continue to support our members.

We recognise that in these unprecedented times the FDA, like many organisations, has multiple obligations it needs to balance. We have been preparing for this eventuality to ensure that we are able to maintain our service to members, look after the wellbeing of our staff and representatives, reduce the risk of spreading the virus and play our part in supporting the civil service at a moment of national crisis.
Our contingency planning hopefully means that we will continue to maintain the services that our members rely on:
- individual advice and representation;
- bargaining and influencing employers;
- campaigning on the issues that are important to our members;
- defending an impartial and professional civil service; and
- supporting career development through FDA Learn and Keyskills.
The coming months will test public services like never before and we are confident that the union can play its part in supporting those who are critical to delivering those services. We have invested in technology to allow us to conduct the vast majority of meetings without the need for travel, and our main functions are already set up to operate remotely.
The next few months would normally be a busy period for the union, with our Annual Delegate Conference and a range of training and learning events for members and reps. We have unfortunately had to make the difficult decision to suspend all FDA Learn events until the end of April. We will of course keep the situation under review and will update members when decisions are made about other upcoming events. We are looking at how we can deliver learning differently given the challenges, and also want to ensure that our programme reflects the new challenges that our members will face.
We recognise that the way in which public services are delivered over the coming months is likely to change dramatically and that our members will face significant challenges at home and work. As ever, the FDA will be here to support civil servants and the vital public services that they deliver.
Related News
-
The future of office work in the civil service report launch
Report author Sufyan Ahmed, CIPD CEO Peter Cheese, AHCPS Deputy General Secretary Paul Malone, and FDA General Secretary Dave Penman discussed the FDA’s findings that 78% of civil servants believe office attendance mandate has failed.
-
78% of civil servants believe office attendance mandate has failed, finds new FDA report
A new report published by the FDA finds that the government’s 60% office attendance mandate has failed to deliver on any of its own objectives to boost productivity, improve collaboration, and help younger workers.
-
Don’t use civil servants as scapegoats for overspend in Northern Ireland
FDA National Officer for Northern Ireland Robert Murtagh spoke to BBC Radio Ulster to challenge claims that senior civil servants were to blame for a projected £2.45 billion overspend in major capital projects.